Plasmodium falciparum strains harboring dihydrofolate reductase with the I164L mutation are absent in Malawi and Zambia even under antifolate drug pressure.

Antimicrobial Agents and Chemotherapy
Edwin O OchongAndrew Owen

Abstract

The Plasmodium falciparum dihydrofolate reductase (PfDHFR) enzyme is the target of pyrimethamine, a component of the antimalarial pyrimethamine-sulfadoxine. Resistance to this drug is associated primarily with mutations in the Pfdhfr gene. The I164L mutant allele is of particular interest, because strains possessing this mutation are highly resistant to pyrimethamine and to chlorproguanil, a component of chlorproguanil-dapsone. A recent study from Malawi reported this mutation at a prevalence of 4.7% in parasites from human immunodeficiency virus-positive pregnant women by using a real-time PCR method. These observations have huge implications for the use of pyrimethamine-sulfadoxine, chlorproguanil-dapsone, and future antifolate-artemisinin combinations in Africa. It was imperative that this finding be rigorously tested. We identified a number of critical limitations in the original genotyping strategy. Using a refined and validated real-time PCR strategy, we report here that this mutation was absent in 158 isolates from Malawi and 42 isolates from Zambia collected between 2003 and 2005.

References

Jan 23, 1999·The American Journal of Pathology·W DietmaierJ Rüschoff
Oct 19, 2000·The American Journal of Tropical Medicine and Hygiene·E K MberuW M Watkins
Jun 8, 2001·Parasitology·S Paget-McNicol, A Saul
Jul 2, 2003·Molecular Biology and Evolution·Shalini NairTim J C Anderson
Dec 3, 2003·Tropical Medicine & International Health : TM & IH·Tim J C AndersonSuna Balkan
Oct 23, 2004·The Journal of Infectious Diseases·Sarah J BatesCarol Hopkins Sibley
Dec 21, 2004·Transactions of the Royal Society of Tropical Medicine and Hygiene·Sivicha KrudsoodSornchai Looareesuwan
Mar 9, 2005·British Journal of Clinical Pharmacology·Andrew OwenMunir Pirmohamed
Mar 23, 2005·Transactions of the Royal Society of Tropical Medicine and Hygiene·Alexis NzilaKevin Marsh
Jul 29, 2005·Antimicrobial Agents and Chemotherapy·Nimol KhimThierry Fandeur
Sep 9, 2006·The Journal of Infectious Diseases·Jean-Pierre Van GeertruydenUmberto D'Alessandro
Nov 10, 2006·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·C V PloweO K Doumbo

❮ Previous
Next ❯

Citations

Mar 21, 2009·Antimicrobial Agents and Chemotherapy·Alisa P AlkerStephen A Ward
Dec 16, 2010·Future Microbiology·Ingrid B Müller, John E Hyde
Jul 25, 2009·Tropical Medicine & International Health : TM & IH·Daniel J BridgesStandwell Nkhoma

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.